Breast Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,??????? ????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,??????? (1) breast cancer patients confirmed by histology or pathology; ? Age 18-70 years old; ? Plan to receive or have received paclitaxel drugs: including solvent paclitaxel, docetaxel, albumin paclitaxel, paclitaxel liposome; ? The estimated survival time is more than 3 months; ? It conforms to the category of syndrome differentiation and treatment of blood arthralgia in traditional Chinese medicine; The patient is unconscious and can communicate with normal language
Exclusion criteria
Exclusion criteria: ? Age 70 years old; ? Peripheral neuropathy caused by other reasons; ? There are heart, liver and kidney insufficiency, cardiovascular disease and endocrine disease; Accompanied by mental and consciousness disorders; Severe skin disease and systemic infection; ? The patient was involuntary.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation scale of peripheral neurotoxicity of chemotherapeutic drugs (EORTC qlq-cipn20);Mental state rating scale;Score of TCM syndrome integral quantitative scale (slefi); | — |
Countries
China
Contacts
National Cancer Center, Chinese Academy of Medical Sciences / Cancer Hospital of Peking Union Medical College